Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.5000
- TODAY'S CHANGE (%)-0.2600 (-6.9149%)
- Bid / Lots3.5100/ 3
- Ask / Lots3.7500/ 2
- Open / Previous Close3.7600 / 3.7600
- Day Range
- 52 Week Range
- Volume1,687,096
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 30508 | 3.66 |
| 09:34 ET | 6601 | 3.675 |
| 09:36 ET | 2700 | 3.68 |
| 09:38 ET | 100 | 3.69 |
| 09:39 ET | 7983 | 3.6599 |
| 09:41 ET | 4100 | 3.6799 |
| 09:43 ET | 6385 | 3.66 |
| 09:45 ET | 3126 | 3.66 |
| 09:48 ET | 7199 | 3.69 |
| 09:50 ET | 6845 | 3.688 |
| 09:52 ET | 4608 | 3.685 |
| 09:54 ET | 2349 | 3.69 |
| 09:56 ET | 3317 | 3.68 |
| 09:57 ET | 2300 | 3.675 |
| 09:59 ET | 600 | 3.67 |
| 10:01 ET | 14700 | 3.66 |
| 10:03 ET | 300 | 3.665 |
| 10:06 ET | 997 | 3.66 |
| 10:08 ET | 2090 | 3.675 |
| 10:10 ET | 8050 | 3.68 |
| 10:12 ET | 5550 | 3.67 |
| 10:14 ET | 4525 | 3.67 |
| 10:15 ET | 13700 | 3.67 |
| 10:17 ET | 3262 | 3.675 |
| 10:19 ET | 600 | 3.6699 |
| 10:21 ET | 3450 | 3.685 |
| 10:24 ET | 8476 | 3.68 |
| 10:26 ET | 23200 | 3.685 |
| 10:28 ET | 4200 | 3.7 |
| 10:30 ET | 3900 | 3.69 |
| 10:32 ET | 7600 | 3.685 |
| 10:33 ET | 1456 | 3.685 |
| 10:35 ET | 872 | 3.68 |
| 10:37 ET | 1304 | 3.685 |
| 10:39 ET | 3090 | 3.685 |
| 10:42 ET | 1738 | 3.68 |
| 10:44 ET | 1000 | 3.685 |
| 10:46 ET | 100 | 3.685 |
| 10:48 ET | 1800 | 3.685 |
| 10:50 ET | 1700 | 3.685 |
| 10:51 ET | 3826 | 3.6906 |
| 10:53 ET | 350 | 3.69 |
| 10:55 ET | 7409 | 3.71 |
| 10:57 ET | 1900 | 3.705 |
| 11:00 ET | 400 | 3.7 |
| 11:02 ET | 100 | 3.6901 |
| 11:04 ET | 3050 | 3.7 |
| 11:08 ET | 24685 | 3.71 |
| 11:09 ET | 2000 | 3.71 |
| 11:11 ET | 10639 | 3.745 |
| 11:13 ET | 1400 | 3.745 |
| 11:15 ET | 1850 | 3.755 |
| 11:18 ET | 5184 | 3.765 |
| 11:20 ET | 8276 | 3.765 |
| 11:22 ET | 8746 | 3.745 |
| 11:24 ET | 200 | 3.745 |
| 11:26 ET | 100 | 3.745 |
| 11:27 ET | 5512 | 3.735 |
| 11:29 ET | 500 | 3.745 |
| 11:33 ET | 5200 | 3.745 |
| 11:36 ET | 200 | 3.745 |
| 11:38 ET | 100 | 3.75 |
| 11:40 ET | 3362 | 3.75 |
| 11:42 ET | 6420 | 3.79 |
| 11:44 ET | 2580 | 3.77 |
| 11:45 ET | 300 | 3.77 |
| 11:47 ET | 620 | 3.77 |
| 11:49 ET | 100 | 3.77 |
| 11:51 ET | 17031 | 3.79 |
| 11:54 ET | 12035 | 3.79 |
| 11:56 ET | 24484 | 3.8 |
| 11:58 ET | 7273 | 3.8 |
| 12:00 ET | 19844 | 3.8 |
| 12:02 ET | 1371 | 3.805 |
| 12:03 ET | 2100 | 3.805 |
| 12:05 ET | 300 | 3.8 |
| 12:07 ET | 31858 | 3.805 |
| 12:09 ET | 24534 | 3.765 |
| 12:12 ET | 15972 | 3.76 |
| 12:14 ET | 1805 | 3.7501 |
| 12:16 ET | 6799 | 3.755 |
| 12:18 ET | 100 | 3.755 |
| 12:20 ET | 600 | 3.755 |
| 12:21 ET | 1997 | 3.76 |
| 12:23 ET | 4391 | 3.755 |
| 12:25 ET | 6399 | 3.745 |
| 12:27 ET | 400 | 3.75 |
| 12:30 ET | 1000 | 3.755 |
| 12:36 ET | 2990 | 3.745 |
| 12:43 ET | 1798 | 3.755 |
| 12:45 ET | 2793 | 3.745 |
| 12:50 ET | 6206 | 3.74 |
| 12:52 ET | 1016 | 3.74 |
| 12:54 ET | 6378 | 3.7268 |
| 12:56 ET | 5000 | 3.72 |
| 12:57 ET | 1997 | 3.73 |
| 12:59 ET | 22600 | 3.7 |
| 01:01 ET | 2500 | 3.6901 |
| 01:06 ET | 300 | 3.69 |
| 01:10 ET | 1900 | 3.695 |
| 01:12 ET | 5199 | 3.7 |
| 01:14 ET | 121 | 3.695 |
| 01:15 ET | 2603 | 3.695 |
| 01:17 ET | 2000 | 3.7 |
| 01:19 ET | 3707 | 3.69 |
| 01:21 ET | 20904 | 3.685 |
| 01:24 ET | 15974 | 3.7 |
| 01:26 ET | 12744 | 3.695 |
| 01:30 ET | 800 | 3.6999 |
| 01:35 ET | 2800 | 3.695 |
| 01:39 ET | 1336 | 3.69 |
| 01:42 ET | 400 | 3.6899 |
| 01:46 ET | 2696 | 3.675 |
| 01:48 ET | 400 | 3.6799 |
| 01:50 ET | 1046 | 3.67 |
| 01:51 ET | 1400 | 3.67 |
| 01:53 ET | 998 | 3.665 |
| 01:55 ET | 700 | 3.665 |
| 01:57 ET | 200 | 3.665 |
| 02:00 ET | 800 | 3.66 |
| 02:02 ET | 100 | 3.665 |
| 02:04 ET | 900 | 3.66 |
| 02:06 ET | 5098 | 3.66 |
| 02:08 ET | 874 | 3.66 |
| 02:09 ET | 600 | 3.66 |
| 02:15 ET | 3811 | 3.66 |
| 02:18 ET | 28965 | 3.615 |
| 02:20 ET | 5450 | 3.625 |
| 02:22 ET | 6350 | 3.62 |
| 02:24 ET | 50100 | 3.62 |
| 02:26 ET | 30527 | 3.605 |
| 02:27 ET | 6350 | 3.595 |
| 02:29 ET | 17839 | 3.59 |
| 02:31 ET | 21090 | 3.585 |
| 02:33 ET | 31807 | 3.623 |
| 02:36 ET | 29299 | 3.595 |
| 02:38 ET | 26811 | 3.595 |
| 02:40 ET | 1200 | 3.5901 |
| 02:42 ET | 11383 | 3.595 |
| 02:44 ET | 24930 | 3.61 |
| 02:45 ET | 1400 | 3.61 |
| 02:47 ET | 6894 | 3.615 |
| 02:49 ET | 950 | 3.615 |
| 02:51 ET | 36759 | 3.605 |
| 02:54 ET | 16853 | 3.615 |
| 02:56 ET | 11600 | 3.615 |
| 02:58 ET | 4850 | 3.615 |
| 03:00 ET | 1150 | 3.615 |
| 03:02 ET | 4197 | 3.605 |
| 03:03 ET | 500 | 3.6 |
| 03:07 ET | 494 | 3.605 |
| 03:09 ET | 38650 | 3.57 |
| 03:12 ET | 41225 | 3.58 |
| 03:14 ET | 22206 | 3.605 |
| 03:16 ET | 9330 | 3.605 |
| 03:18 ET | 3300 | 3.605 |
| 03:20 ET | 1100 | 3.605 |
| 03:21 ET | 3599 | 3.605 |
| 03:23 ET | 300 | 3.6 |
| 03:25 ET | 7130 | 3.605 |
| 03:27 ET | 800 | 3.605 |
| 03:30 ET | 8622 | 3.59 |
| 03:32 ET | 104 | 3.595 |
| 03:34 ET | 5800 | 3.595 |
| 03:36 ET | 3202 | 3.595 |
| 03:38 ET | 100 | 3.595 |
| 03:39 ET | 7839 | 3.595 |
| 03:41 ET | 460 | 3.595 |
| 03:43 ET | 9345 | 3.595 |
| 03:45 ET | 9522 | 3.585 |
| 03:48 ET | 19723 | 3.57 |
| 03:50 ET | 16835 | 3.555 |
| 03:52 ET | 20103 | 3.57 |
| 03:54 ET | 5665 | 3.575 |
| 03:56 ET | 25775 | 3.555 |
| 03:57 ET | 172231 | 3.495 |
| 03:59 ET | 87541 | 3.5 |
Jun 20, 2024
DJ Mereo BioPharma Group Is Maintained at Outperform by Leerink Partners, from 8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 14, 2024
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 13, 2024
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 574.5M | -11.1x | --- |
Immunome Inc | 716.0M | -2.1x | --- |
Stoke Therapeutics Inc | 746.9M | -5.8x | --- |
Mesoblast Ltd | 750.5M | -4.7x | --- |
Dianthus Therapeutics Inc | 749.0M | -7.6x | --- |
CARGO Therapeutics Inc | 713.8M | -5.1x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $574.5M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 152.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-0.31 |
Book Value | $0.45 |
P/E Ratio | -11.1x |
Price/Sales (TTM) | 57.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
